Tamil Nadu pursuing shortfall in supply of pneumococcal conjugate vaccines with Centre

Since April, T.N. has received only about 12.5 lakh doses of the vaccine, while the annual requirement is 30 lakh doses, an official said

Updated - December 01, 2022 04:09 pm IST

Published - December 01, 2022 03:05 pm IST - CHENNAI

A child being administered with the Pneumococcal Conjugate Vaccine (PCV) in Puducherry recently. The vaccine is given in a three-dose schedule

A child being administered with the Pneumococcal Conjugate Vaccine (PCV) in Puducherry recently. The vaccine is given in a three-dose schedule | Photo Credit: M. Samraj

The State government has taken up with the Centre, the issue of shortfall in the supply of Pneumococcal Conjugate Vaccines (PCV), administered to protect children from pneumonia, as it has received not even half of the State’s requirements for this year. 

“We have been told that there are constraints in production. But we have requested the Union government to expedite the supply of the balance portion,” said an official in Chennai.  

An integral part of the country’s universal immunisation programme (UIP) now, the vaccine is available free of cost in the country. It is given in three dose schedules: at 6 weeks, 14 weeks and a booster at 9-12 months. In Tamil Nadu, it is provided to children through government hospitals and primary health centres.

Since April, the State has received about 12.5 lakh doses of the vaccine including 2.3 lakh doses in November. The annual requirement is 30 lakh doses.  “Only this year, we are having such a problem,” pointed out the official, adding that the State government is not aware of the reasons behind the problem. 

Asked why the State government is not making steps to procure the vaccine through the private sector, the official said that when the vaccine was supplied to States free, there was no point in making attempts to buy from the private sector. Besides, the cost of the vaccine is prohibitive as it ranges from ₹2,000 to ₹ 3,800 per dose.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.